This research study is evaluating a new drug called "nivolumab" as a possible treatment for
smoldering multiple myeloma in order to prevent or postpone development of active multiple
- Patients with smoldering multiple myeloma do not have symptoms but are at risk for
progressing to active multiple myeloma. Multiple myeloma is a cancer of the plasma cell,
which is an important part of the immune system. Patients with active multiple myeloma
generally require treatment.